CN102441053B - Traditional Chinese medicine for treating liver cancer - Google Patents
Traditional Chinese medicine for treating liver cancer Download PDFInfo
- Publication number
- CN102441053B CN102441053B CN 201110399307 CN201110399307A CN102441053B CN 102441053 B CN102441053 B CN 102441053B CN 201110399307 CN201110399307 CN 201110399307 CN 201110399307 A CN201110399307 A CN 201110399307A CN 102441053 B CN102441053 B CN 102441053B
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- liver cancer
- grams
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Abstract
The invention belongs to the field of traditional Chinese medicines, and particularly discloses a traditional Chinese medicine for treating liver cancer. The traditional Chinese medicine takes hericium erinaceus, hypericum japonicum thumb, scutellaria baicalensis, Chinese lobelia, polygonum cuspidatum, peach kernel, hawthorn, arachis hypogaea, cortex dictamni, olenlandia diffusa, soffalower carthamus and golden cypress as active ingredients, and is composed according to certain parts in weight. The traditional Chinese medicine is specially used for treating liver cancer, a plurality of medicines are appropriately combined, the synergistic interaction or resistance function of the medicines is utilized, so the curative effect is improved for adapting to the curative requirements of complicated patient conditions, adverse effects are reduced, the curative effect is obvious, the traditional Chinese medicine is safe and reliable, is simple to take, and has better liver cancer curative effect. 60 patients are totally treated, and the total effective rate reaches 86%.
Description
(1) technical field
The invention belongs to the field of Chinese medicines, particularly a kind of Chinese medicine for the treatment of hepatocarcinoma.
(2) background technology
Hepatocarcinoma is one of pertinacious disease that is difficult to cure most in the world at present, and its etiopathogenesis may be relevant with viral hepatitis and liver cirrhosis.China the treatment liver cancer mainly depend on operation, radiotherapy and chemotherapy, but said method in kill cancer cell, the human normal cell comes to harm too, and has the Western medicine of antitumaous effect, side effect is big, curative effect is not obvious, and the expense costliness.At present, Chinese medicine to anticancer, control cancer and in most cases can only play control action, though can mitigate the disease and pain, curative effect is not good enough.
(3) summary of the invention
The present invention provides a kind of Chinese medicine for preparing treatment hepatocarcinoma simple, evident in efficacy in order to remedy the deficiencies in the prior art.
The present invention is achieved through the following technical solutions:
A kind of Chinese medicine for the treatment of hepatocarcinoma, its special character is: its active component is made up of the raw material of following parts by weight:
Hericium erinaceus (Bull. Ex Fr.) Pers. 10-30 part, Herba Hyperici Japonici 15-30 part, Radix Scutellariae 3-9 part
Herba Lobeliae Chinensis 15-30 part, Rhizoma Polygoni Cuspidati 10-15 part, Semen Persicae 6-10 part
Fructus Crataegi 3-10 part, Testa arachidis hypogaeae 10-30 part, Cortex Dictamni 6-15 part
Herba Hedyotidis Diffusae 15-30 part, Flos Carthami 3-10 part, Cortex Phellodendri 3-9 part.
The weight proportion of its preferred each active component is:
20 parts of Hericium erinaceus (Bull. Ex Fr.) Pers.es, 22 parts of Herba Hyperici Japonici, 6 parts of Radix Scutellariaes
23 parts of Herba Lobeliae Chinensis, 12 parts of Rhizoma Polygoni Cuspidati, 8 parts in Semen Persicae
6 parts of Fructus Crataegis, 20 parts of Testa arachidis hypogaeaes, 10 parts of Cortex Dictamni
22 parts of Herba Hedyotidis Diffusaes, 7 parts on Flos Carthami, 6 parts of Cortex Phellodendris.
Chinese medicine of the present invention is tablet.Various raw materials are cleaned up, and dry disinfection is beaten powder and is mixed, and makes tablet according to a conventional method.
Usage and dosage: warm water is taken after mixing it with water, and one day twice, each 5 tablets, one after each meal.
The pharmaceutical characteristic of each active component of the present invention is as follows:
Hericium erinaceus (Bull. Ex Fr.) Pers.: strengthening the spleen and nourishing the stomach, calm the nerves, anticancer.It is weak to cure mainly body void, dyspepsia, insomnia, gastroduodenal ulcer, chronic gastritis, digestive tract tumor;
Herba Hyperici Japonici: clearing away heat-damp and promoting diuresis, removing toxic substances and promoting subsidence of swelling.Cure mainly jaundice due to damp-heat, have loose bowels, dysentery, acute appendicitis, lung abscess, carbuncle furuncle and phyma poison, tonsillitis, aphtha, conjunctival congestion and swelling pain, venom, traumatic injury;
Radix Scutellariae: clearing away heat-fire, the dampness detoxifcation, hemostasis, antiabortive.Cure mainly the cough due to lung-heat, the calentura unconsciousness due to high fever, the liver-fire headache, conjunctival congestion and swelling pain, jaundice due to damp-heat, dysentery, pyretic stranguria is told nosebleed, metrorrhagia, excessive fetal movement due to heat in pregnancy, carbuncle furuncle;
Herba Lobeliae Chinensis: heat-clearing and toxic substances removing, inducing diuresis to remove edema.Cure mainly venom, multiple cancer, the carbuncle furuncle, tonsillitis, the dermatitis rhus jaundice due to damp-heat, the tympanites edema, the eczema tinea pedis, osteopatia sprain swells and ache;
Rhizoma Polygoni Cuspidati: blood circulation promoting and blood stasis dispelling, dampness removing jaundice eliminating, heat-clearing and toxic substances removing.Cure mainly women's amenorrhea, dysmenorrhea, lochiostasis ， lumps in the chest and abdomen, rheumatic arthralgia, jaundice due to damp-heat, stranguria with turbid discharge leukorrhagia, injury from falling down, sore swollen toxin, burn due to hot liquid or fire;
Semen Persicae: blood circulation promoting and blood stasis dispelling, loosening bowel to relieve constipation.Cure mainly dysmenorrhea, amenorrhea due to stagnation of blood, the stagnant stomachache of the stasis of blood in puerperal ， mass in the abdomen caking, traumatic injury, swelling and pain due to blood stasis, lung abscess, acute appendicitis, dryness of the intestine constipation;
Fructus Crataegi: promoting digestion and invigorating the stomach, circulation of qi promoting dissipating blood stasis.Cure mainly eating accumulation, abdominal distention, dysentery, dysmenorrhea due to blood stasis, amenorrhea, puerperal abdonimal pain, lochiorrhea, hernia or painful and swollen testis, hyperlipidemia;
Testa arachidis hypogaeae: hemostasis, dissipating blood stasis, detumescence.Cure mainly hemophilia, hemophilioid disease, constitutional and secondary thrombocytopenic purpura, hepatopathy is hemorrhage, postoperative hemorrhage, cancerous protuberance is hemorrhage, stomach, intestinal, lung, metrorrhagia;
Cortex Dictamni: heat clearing and damp drying, dispelling wind for relieving itching, detoxifcation.Cure mainly the rubella eczema due to the wind heat noxious dampness, scabies, jaundice, wind heat arthralgia chiefly caused by damp pathogen;
Herba Hedyotidis Diffusae: heat-clearing and toxic substances removing, promoting blood circulation and detumescence, dampness removing jaundice eliminating.Cure mainly the lung-heat cough with asthma, lung abscess, laryngopharynx swelling and pain, acute appendicitis, furuncle and phyma skin infection, venom, the puckery pain of pyretic stranguria, edema, dysentery enteritis, jaundice due to damp-heat, cancerous protuberance;
Flos Carthami: promoting blood circulation to restore menstrual flow, stasis-dispelling and pain-killing.Cure mainly the blood stasis amenorrhea, dysmenorrhea, postpartum stagnation stomachache, obstruction of qi in the chest and cardialgia ， lumps in the chest and abdomen, traumatic injury, arthralgia, apoplectic hemiplegia, macule;
Cortex Phellodendri: heat clearing and damp drying, eliminating fire and detoxication.Cure mainly hygropyretic dysentery, have loose bowels, jaundice, nocturnal emission, stranguria with turbid discharge, leukorrhagia, the hectic fever due to YIN-deficiency consumptive fever, flaccidity is preesed, and aphtha of the mouth and tongue, conjunctival congestion and swelling pain, skin sore, skin eczema.
Chinese medicine of the present invention has the effect of heat-clearing and toxic substances removing, the body resistance strengthening and constitution consolidating, regulating the flow of QI to dissipate blood stasis, observing its under ultramicroscope can coup injury and tumoricidal film system, cause cancerous cell cracking collapse, can produce a large amount of lysosome suicide destruction of cancer cells by inducing cancer cell; Energy activated lymphocyte hypertrophy improves the body cell immunologic function; Can promote Kupffer (macrophage) function active, suppress and kill and wound cancerous cell, treatment hepatocarcinoma good effect, effective percentage height by immune system.
Chinese medicine of the present invention is specifically designed to treatment hepatocarcinoma, and multiple medicine is suitably cooperated, and utilizes its mutual collaborative or resistant function, improves curative effect, to adapt to the treatment requirement of the complicated state of an illness, reduce untoward reaction, evident in efficacy, safe and reliable, take simply, hepatocarcinoma there is better therapeutic effect.Treat 60 examples altogether, total effective rate reaches 85%.
(4) specific embodiment
Embodiment 1:
Get Hericium erinaceus (Bull. Ex Fr.) Pers. 20 grams, Herba Hyperici Japonici 22 grams, Radix Scutellariae 6 grams, Herba Lobeliae Chinensis 23 grams, Rhizoma Polygoni Cuspidati 12 grams, Semen Persicae 8 grams, Fructus Crataegi 6 grams, Testa arachidis hypogaeae 20 grams, Cortex Dictamni 10 grams, Herba Hedyotidis Diffusae 22 grams, Flos Carthami 7 grams, Cortex Phellodendri 6 grams, above-mentioned raw materials is cleaned up, dry disinfection, beating powder mixes, make tablet according to a conventional method, quantitatively take.
Usage and dosage: warm water is taken after mixing it with water, and one day twice, each 5 tablets, one after each meal.
Embodiment 2:
Get Hericium erinaceus (Bull. Ex Fr.) Pers. 10 grams, Herba Hyperici Japonici 15 grams, Radix Scutellariae 3 grams, Herba Lobeliae Chinensis 15 grams, Rhizoma Polygoni Cuspidati 10 grams, Semen Persicae 6 grams, Fructus Crataegi 3 grams, Testa arachidis hypogaeae 10 grams, Cortex Dictamni 6 grams, Herba Hedyotidis Diffusae 15 grams, Flos Carthami 3 grams, Cortex Phellodendri 3 grams, above-mentioned raw materials is cleaned up, dry disinfection, beating powder mixes, make tablet according to a conventional method, quantitatively take.
Usage and dosage: warm water is taken after mixing it with water, and one day twice, each 5 tablets, one after each meal.
Embodiment 3:
Get Hericium erinaceus (Bull. Ex Fr.) Pers. 30 grams, Herba Hyperici Japonici 30 grams, Radix Scutellariae 9 grams, Herba Lobeliae Chinensis 30 grams, Rhizoma Polygoni Cuspidati 15 grams, Semen Persicae 10 grams, Fructus Crataegi 10 grams, Testa arachidis hypogaeae 30 grams, Cortex Dictamni 15 grams, Herba Hedyotidis Diffusae 30 grams, Flos Carthami 10 grams, Cortex Phellodendri 9 grams, above-mentioned raw materials is cleaned up, dry disinfection, beating powder mixes, make tablet according to a conventional method, quantitatively take.
Usage and dosage: warm water is taken after mixing it with water, and one day twice, each 5 tablets, one after each meal.
Embodiment 4: clinical observation:
(1) clinical data
The inventor carries out clinical observation treatment to 60 routine liver cancer patients, total effective rate 86% in 2002 so far.By cytodiagnosis, blood routine examination, hepatic and renal function checks, regularly carry out imaging examinations such as rabat, CT, B ultrasonic, three months is a course for the treatment of, takes medicine one more than the course for the treatment of, patient's lump of 64% reduces more than 50%, wherein patient's lump of 42% is eliminated fully, simultaneously the patient is had preferably QI invigorating, enriches blood, regulates function such as immunity, weak, the alopecia that patient after the prevention chemotherapy is occurred, feels sick and General Symptoms such as leukopenia has and prevents preferably and alleviate effect.
(2) Therapeutic Method
Warm water is taken after mixing it with water, and one day twice, each 5 tablets.Calculate treatment time according to the conditions of patients weight, patients with mild was taken about 3 months, and the severe case serve on 12 months and can fully recover.
(3) curative effect determinate standard
" fully alleviate ": the tumor complete obiteration, around keeping more than;
" part is alleviated ": tumor is dwindled more than 50%, around keeping;
" stablize ": tumor is dwindled not as good as 50%, increases to be no more than 25%;
" deterioration ": tumor increases more than 25%.
(4) therapeutic effect:
Clinical complete remission 25 examples account for 42%; Part is alleviated 13 examples, accounts for 22%; Stablize 13 examples, account for 22%; Worsen 9 examples, total effective rate 85%.
The present invention prepares simply, and good absorbing effect is evident in efficacy, has no side effect, and is safe, is conducive to the patient and in time alleviates condition of illness.
Radix Scutellariae has tangible antioxidation, can remove superoxide radical, and the liver protecting is avoided the damage of lipid peroxide; Activating macrophage suppresses cholesterol to the influence of mononuclear cell, macrophage, improves phagocytic rate and the phagocytic index of Turnover of Mouse Peritoneal Macrophages, strengthens intracellular oxidation disinfection ability, makes it stagnate resting stage in cell cycle; By reducing blood coagulation, anticoagulant, thereby inhibition tumor, the cytotoxicity of chemotherapeutics such as enhancing cyclophosphamide.The contained Quercetin of Herba Hyperici Japonici can be removed superoxide anion and hydroxy radical, alleviates the DNA damage that oxygen-derived free radicals causes; Suppress to promote the protein expression of tumor growth, suppress leukaemia's growth, and have fall enzyme, improve liver function, the effect of raise immunity.
The present invention is by the pharmacodynamics requirement of the anticancer centralizing function of Chinese medicine, be that model has been observed tablet of the present invention to inhibition and the life prolongation effect of tumor growth with mice S180 solid tumor, mice Emhorn ascitic type tumor, and observe it to the influence of tumor-bearing mice spleen antibody-producting cell, Turnover of Mouse Peritoneal Macrophages phagocytic function and tumor-bearing mice thymus, spleen weight.The result shows: this tablet can significantly suppress the growth of mice S180 solid tumor, prolong ascitic type mice with tumor life span, and obviously increase the weight of tumor-bearing mice immune organ, and improve the Turnover of Mouse Peritoneal Macrophages phagocytic function, promote the generation of tumor-bearing mice spleen antibody-producting cell simultaneously.
The made tablet clinical test results of the present invention shows: to hepatocarcinoma patients undergoing chemotherapy 20 examples of syndrome of deficiency of both qi and yin; wherein one group of 10 example only used chemotherapeutic; another is organized and also takes the made tablet of the present invention after 10 examples are taken chemotherapeutic; through clinical observation in two months; the liver cancer patient total effective rate that the latter had not only taken chemotherapeutic but also taken the made tablet of the present invention is up to 80%; has notable difference (P＜0.005) with single comparing with the chemotherapeutic group; and clinical symptoms has obvious improvement; quality of life in patients with liver cancer is improved; and the toxicity that chemotherapy causes obviously alleviates; show the effect that the made tablet of the present invention has protection and improves immunologic function, and experimental result shows that peripheral hemogram is also had obvious protective effect.
Survival rate:
Existence example number more than 5 years is 5 examples, and survival rate is 50%, illustrates that tablet of the present invention has notable therapeutic effect.
Model case:
1, Chen is the hepatocarcinoma initial stage by hospital diagnosis, takes the embodiment of the invention 1 made tablet, and warm water is taken after mixing it with water, one day twice, and each 5 tablets, the basic recovery normally continues to take inspection after four months after two months, recovers normal.
2, Lu is hepatocarcinoma mid-term by hospital diagnosis, takes the embodiment of the invention 2 made tablets, and warm water is taken after mixing it with water, one day twice, and each 5 tablets, stable disease after three months continued to take four months, the basic recovery normally.
3, blue certain, be later period of hepatocarcinoma by hospital diagnosis, take the embodiment of the invention 3 made tablets, warm water is taken after mixing it with water, one day twice, each 5 tablets checked after 5 months that stable disease continued to take 5 months, lump dwindles, cancerous cell is not seen diffusion.
Claims (3)
1. Chinese medicine for the treatment of hepatocarcinoma, it is characterized by: its active component is made up of the raw material of following parts by weight:
Hericium erinaceus (Bull. Ex Fr.) Pers. 10-30 part, Herba Hyperici Japonici 15-30 part, Radix Scutellariae 3-9 part
Herba Lobeliae Chinensis 15-30 part, Rhizoma Polygoni Cuspidati 10-15 part, Semen Persicae 6-10 part
Fructus Crataegi 3-10 part, Testa arachidis hypogaeae 10-30 part, Cortex Dictamni 6-15 part
Herba Hedyotidis Diffusae 15-30 part, Flos Carthami 3-10 part, Cortex Phellodendri 3-9 part.
2. the Chinese medicine for the treatment of hepatocarcinoma according to claim 1, it is characterized by: its active component is made up of the raw material of following parts by weight:
20 parts of Hericium erinaceus (Bull. Ex Fr.) Pers.es, 22 parts of Herba Hyperici Japonici, 6 parts of Radix Scutellariaes
23 parts of Herba Lobeliae Chinensis, 12 parts of Rhizoma Polygoni Cuspidati, 8 parts in Semen Persicae
6 parts of Fructus Crataegis, 20 parts of Testa arachidis hypogaeaes, 10 parts of Cortex Dictamni
22 parts of Herba Hedyotidis Diffusaes, 7 parts on Flos Carthami, 6 parts of Cortex Phellodendris.
3. the Chinese medicine for the treatment of hepatocarcinoma according to claim 1 and 2, it is characterized in that: described Chinese medicine is tablet.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110399307 CN102441053B (en) | 2011-12-06 | 2011-12-06 | Traditional Chinese medicine for treating liver cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110399307 CN102441053B (en) | 2011-12-06 | 2011-12-06 | Traditional Chinese medicine for treating liver cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102441053A CN102441053A (en) | 2012-05-09 |
| CN102441053B true CN102441053B (en) | 2013-09-11 |
Family
ID=46004313
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201110399307 Active CN102441053B (en) | 2011-12-06 | 2011-12-06 | Traditional Chinese medicine for treating liver cancer |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102441053B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102698042B (en) * | 2012-05-28 | 2013-10-16 | 济南伟传信息技术有限公司 | Traditional Chinese medicine for treating liver cancer |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1216256A (en) * | 1997-11-05 | 1999-05-12 | 参天堂制药株式会社 | Galenic preparation for prevention and treatment of hepatocarcinoma |
| CN1245692A (en) * | 1998-08-24 | 2000-03-01 | 马跃春 | Chinese medicine preparation for curing cancer and tumor |
| CN1401340A (en) * | 2001-08-12 | 2003-03-12 | 张淑英 | Health product for liver cancer and preparing process thereof |
-
2011
- 2011-12-06 CN CN 201110399307 patent/CN102441053B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1216256A (en) * | 1997-11-05 | 1999-05-12 | 参天堂制药株式会社 | Galenic preparation for prevention and treatment of hepatocarcinoma |
| CN1245692A (en) * | 1998-08-24 | 2000-03-01 | 马跃春 | Chinese medicine preparation for curing cancer and tumor |
| CN1401340A (en) * | 2001-08-12 | 2003-03-12 | 张淑英 | Health product for liver cancer and preparing process thereof |
Non-Patent Citations (6)
| Title |
|---|
| 中药复方及有效成分对肝细胞凋亡的影响;胡聪等;《中医药学报》;20010220;第29卷(第01期);全文 * |
| 侯华新等.几种天然药物提取物抗氧化活性和对肿瘤细胞杀伤作用的比较研究.《中国现代医学杂志》.2003,第13卷(第05期),全文. |
| 几种天然药物提取物抗氧化活性和对肿瘤细胞杀伤作用的比较研究;侯华新等;《中国现代医学杂志》;20030310;第13卷(第05期);全文 * |
| 原发性肝癌的辨证治疗;摘自《陕西中医》;《江苏中医药》;19920430(第04期);全文 * |
| 摘自《陕西中医》.原发性肝癌的辨证治疗.《江苏中医药》.1992,(第04期),全文. |
| 胡聪等.中药复方及有效成分对肝细胞凋亡的影响.《中医药学报》.2001,第29卷(第01期),全文. |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102441053A (en) | 2012-05-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102362947B (en) | Chinese medicine for treating cough | |
| CN102319336B (en) | Traditional Chinese medicine for treating gastritis | |
| CN103272162B (en) | Traditional Chinese medicine composition for treating infertility and preparation method thereof | |
| CN103251865B (en) | Traditional Chinese medicine composite for treating diarrhea | |
| CN105688034A (en) | Application of traditional Chinese medicine composition in preparation of medicines for treating postcholecystectomy syndrome | |
| CN102441053B (en) | Traditional Chinese medicine for treating liver cancer | |
| CN103520652B (en) | Traditional Chinese medicine composition for treating liver cancer | |
| CN103520697A (en) | Traditional Chinese medicine for treating qi-yin deficiency syndrome type chest stuffiness and pains | |
| CN103908616B (en) | The medicament of tumor remission patient radiotherapy side effect and preparation method | |
| CN102389465B (en) | Traditional Chinese medicine composition for treating gastropathy and its preparation method | |
| CN102274399B (en) | Chinese medicine for treating neurasthenia | |
| CN105168522A (en) | Medicament for treating abdominal distension and preparation method thereof | |
| CN102698042B (en) | Traditional Chinese medicine for treating liver cancer | |
| CN104758466A (en) | Traditional Chinese medicine preparation for treating acute cholecystitis and preparation method of traditional Chinese medicine preparation | |
| CN104027447A (en) | Traditional Chinese medicine for treating cancer | |
| CN102631449A (en) | Chinese medicinal composition for treating acute pancreatitis | |
| CN103784574B (en) | A kind of Chinese medicine for oral administration preventing and treating hemolytic disease of newborn | |
| CN103028028B (en) | Traditional Chinese medicine agent for treating primary hepatic carcinoma | |
| CN106334140A (en) | Traditional Chinese medicine composition and preparation method thereof | |
| CN105878716A (en) | Chinese herbal medicine compound preparation for preventing and treating chicken hydropericardium syndrome | |
| CN105749060A (en) | Traditional Chinese medicine composition for treating fetal jaundice | |
| CN103893486A (en) | Traditional Chinese medicine composition for treating liver cancer | |
| CN105079580A (en) | Traditional Chinese medicine composition for treating wind-warm lung-heat disease | |
| CN104306898A (en) | Orally taken traditional Chinese medicine for treating hysteromyoma | |
| CN102580008B (en) | Chinese medicine for treating epigastric pain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: JINAN WEICHUAN INFORMATION TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: JING QINIAN Effective date: 20130802 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent of invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Geng Xiufang Inventor after: Chen Huiyuan Inventor after: Zhao Baiying Inventor before: Jing Qinian |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: JING QINIAN TO: GENG XIUFANG CHEN HUIYUAN ZHAO BAIYING Free format text: CORRECT: ADDRESS; FROM: 250100 JINAN, SHANDONG PROVINCE TO: 250000 JINAN, SHANDONG PROVINCE |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20130802 Address after: 250000 No. 4569 Fenghuang Road, hi tech Zone, Shandong, Ji'nan Applicant after: JINAN WEICHUAN INFORMATION TECHNOLOGY Co.,Ltd. Address before: 250100 No. 251 West Zhou road, Licheng District, Shandong, Ji'nan Applicant before: Jing Qinian |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: HAIMEN JINQILIN ROSEWOOD INVESTMENT AND DEVELOPMEN Free format text: FORMER OWNER: CHEN KAI Effective date: 20140708 Owner name: CHEN KAI Free format text: FORMER OWNER: JINAN WEICHUAN INFORMATION TECHNOLOGY CO., LTD. Effective date: 20140708 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 226000 NANTONG, JIANGSU PROVINCE TO: 226100 NANTONG, JIANGSU PROVINCE Free format text: CORRECT: ADDRESS; FROM: 250000 JINAN, SHANDONG PROVINCE TO: 226000 NANTONG, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20140708 Address after: 226100 Nantong, Haimen City, Haimen City, Hai Tong Road, No. 207 Patentee after: HAIMEN JINQILIN REDWOOD INVESTMENT DEVELOPMENT Co.,Ltd. Address before: 226000 Bamboo Road, bamboo row Town, Nantong Development Zone, Jiangsu 19-11, China Patentee before: Chen Kai Effective date of registration: 20140708 Address after: 226000 Bamboo Road, bamboo row Town, Nantong Development Zone, Jiangsu 19-11, China Patentee after: Chen Kai Address before: 250000 No. 4569 Fenghuang Road, hi tech Zone, Shandong, Ji'nan Patentee before: JINAN WEICHUAN INFORMATION TECHNOLOGY Co.,Ltd. |